INC Research/inVentiv Health Reports Third Quarter 2017 Results

Go back to INC Research/inVentiv Health Reports Third Quarter 2017 Results

INC Research Holdings (INCR) PT Lowered to $46 at Baird Following 3Q Miss

November 10, 2017 9:16 AM EST

Baird lowered its price target on INC Research Holdings (NASDAQ: INCR) to $46.00 (from $67.00) while maintaining a Outperform rating following 3Q. Pro forma adjusted revenue of $767M was down 2%/6% QQ/YY and missed estimates by 1%. Pro forma adjusted EBITDA of $139M... More